There is more to the comparison, and in the sections below, we discuss why we think BMY will outperform JNJ in the next three ...

We recently published a list of 10 Stocks That Are Close To Becoming Dividend Aristocrats. In this article, we are going to ...

Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Income investors are drawn to Aristocrats because these stocks have consistently increased their dividends for decades.

Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Shareholder Yield Investor model based on the ...

Bristol-Myers Squibb (NYSE: BMY) is the kind of stock that potentially has a lot to offer to investors looking for ...

On Wednesday, Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $59.27 which represents a slight increase of $0.53 or 0.90% from the prior close of $58.74. The stock opened at ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

Purple Biotech PPBT, a clinical-stage oncology company, reported positive final results from the mid-stage study of its lead ...

The business also recently announced a dividend, which will be paid on Friday, November 29th. Shareholders of record on Thursday, October 31st will be paid a GBX 3.89 ($0.05) dividend. The ex ...